Cargando…
A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience
BACKGROUND: Cancer is a major burden of disease in low- and middle-income countries (LMICs) yet financial barriers limit access to life-saving oncology drugs. Medical donation and other drug access programs can help improve patient access to essential medicines, such as quality assured oncology drug...
Autores principales: | Novakowski, Ann Kim, Garcia-Gonzalez, Pat, Wrigglesworth, Michael, Stergachis, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062918/ https://www.ncbi.nlm.nih.gov/pubmed/30053910 http://dx.doi.org/10.1186/s12992-018-0391-4 |
Ejemplares similares
-
Assessment of the scope and practice of evaluation among medical donation programs
por: Jenny, Alisa M., et al.
Publicado: (2016) -
Translating medicines to patients: A novel methodology for quantifying the global medical supplies and donations program
por: Li, Shang-Ju, et al.
Publicado: (2018) -
Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries
por: Kovacs, Stephanie D., et al.
Publicado: (2017) -
Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014) -
A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals
por: Stergachis, Andy, et al.
Publicado: (2010)